ArticleThe Journal of allergy and clinical immunology2021

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2.

Terrie S Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.